Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2026-06-06 @ 6:10 AM
Study NCT ID:
NCT01107951
Status:
COMPLETED
Last Update Posted:
2013-03-22
First Post:
2010-04-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Low-dose Rituximab and High-dose Dexamethasone as First Line Treatment for ITP
Sponsor:
Hospital Universitario Dr. Jose E. Gonzalez
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Rituximab in PTI 001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None